Hartmut Weiler Selected Research

Rivaroxaban

1/2019

Myeloid cell-synthesized coagulation factor X dampens antitumor immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hartmut Weiler Research Topics

Disease

13	Inflammation (Inflammations) 01/2024 - 11/2003
11	Sepsis (Septicemia) 11/2015 - 11/2003
10	Thrombosis (Thrombus) 01/2023 - 09/2004
9	Hemorrhage 10/2022 - 10/2007
9	Endotoxemia 11/2015 - 11/2003
7	Hemophilia A (Haemophilia) 01/2020 - 07/2006
3	Neoplasms (Cancer) 12/2023 - 09/2011
3	Infections 11/2015 - 04/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2013 - 09/2002
2	Fibrosis (Cirrhosis) 01/2023 - 11/2016
2	Type 2 von Willebrand Disease 10/2022 - 01/2022
2	Cardiomyopathies (Cardiomyopathy) 02/2016 - 03/2006
2	Activated Protein C Resistance (APC Resistance) 11/2015 - 05/2014
2	Thrombophilia 01/2013 - 09/2009
2	Atherosclerosis 01/2013 - 09/2009
2	Lymphopenia (Lymphocytopenia) 05/2011 - 12/2008
1	Skin Diseases (Skin Disease) 01/2024
1	Contact Dermatitis (Eczema, Contact) 01/2024
1	Allergic Contact Dermatitis 01/2024
1	Wounds and Injuries (Trauma) 12/2023
1	Experimental Arthritis 05/2023
1	Arthritis (Polyarthritis) 05/2023
1	Rheumatoid Arthritis 05/2023
1	Carotid Artery Injuries 10/2021
1	Acute Radiation Syndrome 01/2021
1	Disease Susceptibility (Diathesis) 01/2020
1	Type 3 von Willebrand Disease 01/2020
1	von Willebrand Diseases (von Willebrand's Disease) 01/2020
1	Neonatal Alloimmune Thrombocytopenia 11/2018
1	Transfusion Reaction 11/2018
1	Fatty Liver 08/2017
1	Weight Gain 08/2017
1	Obesity 08/2017
1	Idiopathic Pulmonary Fibrosis 11/2016
1	Disease Progression 11/2016
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2016
1	Cardiomegaly (Heart Hypertrophy) 02/2016
1	Heart Diseases (Heart Disease) 02/2016
1	Disseminated Intravascular Coagulation 06/2015
1	Pulmonary Embolism 06/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2015

Drug/Important Bio-Agent (IBA)

16	Protein CIBA 12/2023 - 11/2003
10	Thrombin FDA Link 01/2020 - 03/2004
9	AnticoagulantsIBA 12/2023 - 10/2007
8	ThrombomodulinIBA 08/2017 - 09/2004
7	Factor VIII (Coagulation Factor VIII)IBA 10/2022 - 07/2006
6	Endothelial Protein C ReceptorIBA 01/2024 - 10/2007
6	Thromboplastin (Tissue Factor)IBA 12/2023 - 08/2008
6	FibrinIBA 01/2021 - 03/2004
5	Peptide Hydrolases (Proteases)FDA Link 12/2022 - 09/2009
4	AntibodiesIBA 11/2018 - 07/2006
4	Fibrinogen (Factor I)FDA Link 08/2017 - 03/2004
4	Proteins (Proteins, Gene)FDA Link 02/2016 - 10/2007
4	EndotoxinsIBA 08/2010 - 09/2002
4	factor V LeidenIBA 08/2010 - 11/2003
3	von Willebrand FactorIBA 10/2022 - 01/2020
3	Hemostatics (Antihemorrhagics)IBA 10/2021 - 03/2004
3	LipopolysaccharidesIBA 04/2015 - 05/2004
3	prolyl-proline (Pro-Pro)IBA 01/2013 - 09/2009
2	Factor VIIa (Activated Factor VII)IBA 03/2024 - 07/2018
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2023 - 06/2015
2	PAR-2 ReceptorIBA 12/2022 - 10/2008
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022 - 04/2015
2	LigandsIBA 08/2020 - 01/2019
2	AntithrombinsIBA 08/2017 - 06/2015
2	estropipate (Ogen)FDA LinkGeneric 08/2017 - 06/2015
2	Cell Surface ReceptorsIBA 04/2015 - 02/2010
2	CytokinesIBA 02/2015 - 09/2002
2	CoagulantsIBA 01/2013 - 03/2009
2	Apolipoproteins E (ApoE)IBA 01/2013 - 09/2009
2	LectinsIBA 09/2011 - 09/2002
1	3K3A-APC proteinIBA 01/2024
1	Proteinase-Activated ReceptorsIBA 01/2024
1	Nucleic AcidsIBA 12/2023
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2023
1	HaptensIBA 12/2022
1	MorpholinosIBA 01/2022
1	OligonucleotidesIBA 01/2022
1	DianisidineIBA 01/2022
1	ferric chlorideIBA 10/2021
1	RivaroxabanIBA 01/2019
1	Factor X (Stuart Factor)IBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	Human Platelet AntigensIBA 11/2018
1	recombinant FVIIa (rFVIIa)FDA Link 07/2018
1	Dabigatran FDA Link 08/2017
1	Glucose (Dextrose)FDA LinkGeneric 08/2017
1	Hydroxyproline (4 Hydroxyproline)IBA 11/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 11/2016
1	Natriuretic PeptidesIBA 02/2016
1	CateninsIBA 02/2016
1	Serum Response FactorIBA 02/2016
1	N-propionylprocainamideIBA 02/2016
1	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 02/2016
1	Protein SIBA 11/2015

Therapy/Procedure

7	Therapeutics 10/2021 - 09/2008
2	Transplantation 01/2023 - 10/2008
1	Surgical Amputation (Amputations) 10/2022
1	Lasers (Laser) 10/2021
1	Immunotherapy 01/2019